Table 3. – The association between hypertension grade and disease severity in COVID-19 patients with hypertension.
| Hypertension grade | |||||
|---|---|---|---|---|---|
|
| |||||
| Total (n=112) | I (n=73) | II (n=24) | III (n=15) | p-value | |
| Disease severity | 0.0003a | ||||
| Moderate | 20(17.8) | 12(16.4) | 8(33.3) | 0(0) | |
| Severe | 69(61.6) | 50(68.5) | 13((54.2) | 6(40) | |
| Critical | 23(19.3) | 11(15.1) | 3(12.5) | 9(60) | |
| Clinical outcomes | 0.0006b | ||||
| Discharge | 92(82.1) | 64(87.7) | 21(87.5) | 7(46.7) | |
| Death | 20(17.9) | 9(12.3) | 3(12.5) | 8(53.3) | |
a: Kruskal-Wallis was used to analyze the relationship between disease severity and hypertension grades. b: R X C The Chi-square test was used to analyze the relationship between clinical outcomes and hypertension grades.